Kosmin A S, Wishart P K, Ridges P J
J Cataract Refract Surg. 1998 Feb;24(2):249-55. doi: 10.1016/s0886-3350(98)80207-1.
To compare long-term intraocular pressure (IOP) control after extracapsular cataract extraction and intraocular lens (IOL) implantation combined with trabeculectomy (ECCE + TRAB) with that after phacotrabeculectomy and IOL implantation.
Glaucoma Unit, Royal Liverpool University Hospital, Liverpool, England.
This retrospective study comprised 32 eyes having ECCE + TRAB and 31 eyes having phacotrabeculectomy with a mean follow-up of 37.5 and 41.0 months, respectively. The need for pressure-lowering medication was recorded. Kaplan-Meier curves were created for each group.
At every measurement after 3 weeks of follow-up, significantly fewer eyes in the phacotrabeculectomy group required IOP-lowering medication (P = .04).
After both ECCE + TRAB and phacotrabeculectomy, IOP control was achieved in significantly more eyes on fewer pressure-lowering medications than preoperatively. Phacotrabeculectomy with IOL implantation led to better unaided long-term postoperative IOP control than ECCE + TRAB with IOL implantation.
比较白内障囊外摘除联合人工晶状体植入术与小梁切除术(ECCE + TRAB)后与超声乳化小梁切除术联合人工晶状体植入术后的长期眼压(IOP)控制情况。
英国利物浦皇家利物浦大学医院青光眼科。
这项回顾性研究包括32例行ECCE + TRAB的患眼和31例行超声乳化小梁切除术的患眼,平均随访时间分别为37.5个月和41.0个月。记录降低眼压药物的使用需求。为每组绘制Kaplan-Meier曲线。
随访3周后的每次测量中,超声乳化小梁切除术组中需要降低眼压药物的患眼明显较少(P = 0.04)。
ECCE + TRAB和超声乳化小梁切除术后,与术前相比,使用较少的降眼压药物即可使更多患眼实现眼压控制。超声乳化小梁切除术联合人工晶状体植入术比ECCE + TRAB联合人工晶状体植入术能实现更好的术后长期眼压控制。